SEC 13F Intelligence

Nkcfo LLC / VRTX

Nkcfo LLC’s Vertex Pharmaceuticals Inc Position

Does Nkcfo LLC own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 8.2K shares worth $4M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q3 2024
Shares
8.2K
% of Portfolio
+1.83%
Quarters Held
12
position exited

Position History VRTX

Reported value by quarter
Q4 ’21: $99,000Q4 ’21Q1 ’22: $2MQ2 ’22: $2MQ2 ’22Q3 ’22: $2MQ4 ’22: $2MQ4 ’22Q1 ’23: $3MQ2 ’23: $3MQ2 ’23Q3 ’23: $3MQ4 ’23: $3MQ4 ’23Q1 ’24: $4MQ2 ’24: $4MQ2 ’24Q3 ’24: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20248.2K$4M+1.83%
Q2 20248.2K$4M+2.11%
Q1 20248.4K$4M+2.09%
Q4 20238.4K$3M+1.86%
Q3 20238.4K$3M+1.63%
Q2 20238.4K$3M+1.37%
Q1 20238.6K$3M+1.30%
Q4 20228.6K$2M+1.16%
Q3 20228.5K$2M+1.14%
Q2 20228.5K$2M+0.84%
Q1 20228.5K$2M+0.69%
Q4 2021450$99,000+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nkcfo LLC’s full portfolio or all institutional holders of VRTX.